Share Price and Basic Stock Data
Last Updated: December 8, 2025, 3:02 pm
| PEG Ratio | 0.00 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Repro India Ltd operates primarily in the printing, publishing, and stationery sector, a niche market that has seen fluctuating demand patterns. As per the most recent financials, the company reported total sales of ₹470 Cr for the trailing twelve months (TTM), which reflects a recovery trajectory from the lows of ₹287 Cr in FY 2022. The revenue trend appears to be stabilizing, with a notable increase to ₹422 Cr in FY 2023 and ₹479 Cr in FY 2024, signaling a rebound post-pandemic. However, the latest quarterly data indicates a slight decline in sales to ₹116.87 Cr in September 2023 from ₹121.05 Cr in March 2023, which raises questions about sustainability amidst potential seasonal fluctuations and competition in the sector. The company’s ability to maintain sales momentum will be crucial for its long-term growth strategy.
Profitability and Efficiency Metrics
Profitability metrics for Repro India reflect a mixed bag, with an operating profit margin (OPM) of 5.93% reported in the latest quarter, down from a more favorable 11.30% in March 2023. This decline is concerning as it suggests that rising operational costs may be eroding profitability. The net profit for the latest quarter showed a loss of ₹2.73 Cr, which is a stark contrast to the ₹5.06 Cr profit recorded in March 2023. Efficiency ratios like return on equity (ROE) and return on capital employed (ROCE) stood at a mere 0.51% and 1.56%, respectively, indicating that the company is struggling to generate significant returns on shareholder investments. The cash conversion cycle, currently at 50 days, appears manageable but warrants scrutiny as the company navigates its operational efficiencies.
Balance Sheet Strength and Financial Ratios
Repro India’s balance sheet reveals a cautious approach to leverage, with total borrowings recorded at ₹127 Cr against reserves of ₹345 Cr, which provides a comfortable cushion against financial instability. The debt-to-equity ratio stands at 0.18, indicating low reliance on debt for funding operations. However, the interest coverage ratio (ICR) at 4.52x suggests that the company can comfortably meet its interest obligations. On the downside, the book value per share has shown a slight decline from ₹270.89 in FY 2024 to ₹266.90 in FY 2025, reflecting potential pressures on asset valuations. The company’s ability to maintain a robust financial position will be critical as it faces challenges in profitability and revenue growth.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Repro India demonstrates a diverse ownership structure, with promoters holding 46.78% of the equity, while public shareholders account for a significant 44.04%. Foreign institutional investors (FIIs) hold 9.08%, indicating a moderate level of foreign interest. Notably, the gradual decline in promoter shareholding from 51.42% in March 2023 to the current levels may raise some red flags regarding insider confidence in the company’s future prospects. The number of shareholders has also decreased slightly to 9,777, which could indicate waning interest or confidence among retail investors. This diverse ownership base is a strength, but the shift in promoter stakes could lead to uncertainty about the company’s strategic direction.
Outlook, Risks, and Final Insight
Looking ahead, Repro India faces a blend of opportunities and challenges. The company is poised for potential growth as it capitalizes on the recovering demand in the printing sector, yet risks loom large. The declining profitability and efficiency metrics could deter investor confidence if not addressed promptly. Additionally, external factors such as competition and economic fluctuations could impact revenue streams. Investors should remain vigilant about the company’s operational performance and its ability to convert sales into profits. The mixed signals from the financials suggest that while there may be potential for recovery, significant risks exist that could affect future performance. A careful evaluation of the company’s strategic initiatives and market positioning will be essential for investors considering Repro India Ltd as part of their portfolio.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Repro India Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| H T Media Ltd | 539 Cr. | 23.2 | 28.6/14.5 | 25.1 | 71.0 | 0.00 % | 2.51 % | 0.03 % | 2.00 |
| Gala Global Products Ltd | 12.0 Cr. | 2.19 | 4.25/2.16 | 6.54 | 0.00 % | 2.28 % | 13.0 % | 5.00 | |
| Flair Writing Industries Ltd | 3,029 Cr. | 287 | 357/194 | 25.6 | 100.0 | 0.35 % | 15.6 % | 11.9 % | 5.00 |
| Doms Industries Ltd | 15,782 Cr. | 2,600 | 3,115/2,092 | 73.5 | 181 | 0.12 % | 26.2 % | 22.3 % | 10.0 |
| DB Corp Ltd | 4,527 Cr. | 254 | 344/189 | 13.1 | 129 | 4.72 % | 21.1 % | 16.7 % | 10.0 |
| Industry Average | 2,522.31 Cr | 412.71 | 84.29 | 207.90 | 1.10% | 9.42% | 9.72% | 6.27 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 105.46 | 90.35 | 105.09 | 121.05 | 119.53 | 116.87 | 115.91 | 127.15 | 112.29 | 104.66 | 125.94 | 123.06 | 116.47 |
| Expenses | 96.70 | 81.33 | 93.31 | 107.37 | 106.71 | 105.25 | 102.79 | 112.99 | 102.96 | 100.96 | 115.57 | 114.65 | 109.56 |
| Operating Profit | 8.76 | 9.02 | 11.78 | 13.68 | 12.82 | 11.62 | 13.12 | 14.16 | 9.33 | 3.70 | 10.37 | 8.41 | 6.91 |
| OPM % | 8.31% | 9.98% | 11.21% | 11.30% | 10.73% | 9.94% | 11.32% | 11.14% | 8.31% | 3.54% | 8.23% | 6.83% | 5.93% |
| Other Income | 0.15 | 0.43 | 0.08 | 0.45 | 0.35 | 0.90 | 0.07 | 0.83 | 0.53 | 1.52 | 0.47 | 3.94 | 1.14 |
| Interest | 2.44 | 3.05 | 2.75 | 2.74 | 2.79 | 3.11 | 1.71 | 2.12 | 2.14 | 2.05 | 2.05 | 2.22 | 2.09 |
| Depreciation | 6.30 | 5.96 | 6.04 | 6.40 | 7.30 | 7.42 | 7.44 | 7.51 | 7.58 | 7.62 | 7.60 | 8.53 | 8.41 |
| Profit before tax | 0.17 | 0.44 | 3.07 | 4.99 | 3.08 | 1.99 | 4.04 | 5.36 | 0.14 | -4.45 | 1.19 | 1.60 | -2.45 |
| Tax % | 0.00% | 0.00% | 0.00% | -1.40% | 1.30% | 2.01% | 0.00% | 44.40% | 7.14% | 0.00% | 1.68% | 29.38% | 11.43% |
| Net Profit | 0.17 | 0.44 | 3.07 | 5.06 | 3.04 | 1.95 | 4.04 | 2.98 | 0.13 | -4.45 | 1.17 | 1.13 | -2.73 |
| EPS in Rs | 0.13 | 0.35 | 2.41 | 3.98 | 2.29 | 1.37 | 2.83 | 2.08 | 0.09 | -3.11 | 0.82 | 0.79 | -1.91 |
Last Updated: August 20, 2025, 4:30 am
Below is a detailed analysis of the quarterly data for Repro India Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 116.47 Cr.. The value appears to be declining and may need further review. It has decreased from 123.06 Cr. (Mar 2025) to 116.47 Cr., marking a decrease of 6.59 Cr..
- For Expenses, as of Jun 2025, the value is 109.56 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 114.65 Cr. (Mar 2025) to 109.56 Cr., marking a decrease of 5.09 Cr..
- For Operating Profit, as of Jun 2025, the value is 6.91 Cr.. The value appears to be declining and may need further review. It has decreased from 8.41 Cr. (Mar 2025) to 6.91 Cr., marking a decrease of 1.50 Cr..
- For OPM %, as of Jun 2025, the value is 5.93%. The value appears to be declining and may need further review. It has decreased from 6.83% (Mar 2025) to 5.93%, marking a decrease of 0.90%.
- For Other Income, as of Jun 2025, the value is 1.14 Cr.. The value appears to be declining and may need further review. It has decreased from 3.94 Cr. (Mar 2025) to 1.14 Cr., marking a decrease of 2.80 Cr..
- For Interest, as of Jun 2025, the value is 2.09 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 2.22 Cr. (Mar 2025) to 2.09 Cr., marking a decrease of 0.13 Cr..
- For Depreciation, as of Jun 2025, the value is 8.41 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 8.53 Cr. (Mar 2025) to 8.41 Cr., marking a decrease of 0.12 Cr..
- For Profit before tax, as of Jun 2025, the value is -2.45 Cr.. The value appears to be declining and may need further review. It has decreased from 1.60 Cr. (Mar 2025) to -2.45 Cr., marking a decrease of 4.05 Cr..
- For Tax %, as of Jun 2025, the value is 11.43%. The value appears to be improving (decreasing) as expected. It has decreased from 29.38% (Mar 2025) to 11.43%, marking a decrease of 17.95%.
- For Net Profit, as of Jun 2025, the value is -2.73 Cr.. The value appears to be declining and may need further review. It has decreased from 1.13 Cr. (Mar 2025) to -2.73 Cr., marking a decrease of 3.86 Cr..
- For EPS in Rs, as of Jun 2025, the value is -1.91. The value appears to be declining and may need further review. It has decreased from 0.79 (Mar 2025) to -1.91, marking a decrease of 2.70.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: October 15, 2025, 4:33 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 421 | 396 | 384 | 321 | 299 | 399 | 367 | 138 | 287 | 422 | 479 | 466 | 470 |
| Expenses | 353 | 348 | 358 | 297 | 285 | 355 | 322 | 143 | 274 | 378 | 428 | 434 | 441 |
| Operating Profit | 68 | 47 | 26 | 25 | 14 | 45 | 46 | -5 | 13 | 44 | 52 | 32 | 29 |
| OPM % | 16% | 12% | 7% | 8% | 5% | 11% | 12% | -4% | 5% | 10% | 11% | 7% | 6% |
| Other Income | 4 | 11 | 4 | 3 | 28 | 0 | 1 | 1 | 1 | 1 | 2 | 6 | 7 |
| Interest | 19 | 12 | 19 | 16 | 13 | 11 | 10 | 15 | 12 | 11 | 10 | 8 | 8 |
| Depreciation | 18 | 20 | 21 | 14 | 14 | 15 | 19 | 28 | 27 | 25 | 30 | 31 | 32 |
| Profit before tax | 34 | 26 | -10 | -3 | 15 | 19 | 18 | -47 | -24 | 9 | 14 | -2 | -4 |
| Tax % | 23% | 26% | -3% | -78% | -10% | -24% | -7% | -7% | -4% | -1% | 17% | 36% | |
| Net Profit | 26 | 19 | -10 | -1 | 16 | 24 | 19 | -43 | -23 | 9 | 12 | -2 | -5 |
| EPS in Rs | 24.18 | 17.46 | -8.76 | -0.50 | 14.26 | 20.51 | 15.55 | -35.88 | -18.24 | 6.86 | 8.40 | -1.44 | -3.41 |
| Dividend Payout % | 41% | 57% | -34% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -26.92% | -152.63% | 90.00% | 1700.00% | 50.00% | -20.83% | -326.32% | 46.51% | 139.13% | 33.33% | -116.67% |
| Change in YoY Net Profit Growth (%) | 0.00% | -125.71% | 242.63% | 1610.00% | -1650.00% | -70.83% | -305.48% | 372.83% | 92.62% | -105.80% | -150.00% |
Repro India Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 2% |
| 5 Years: | 5% |
| 3 Years: | 17% |
| TTM: | 0% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 24% |
| TTM: | -154% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 2% |
| 5 Years: | 3% |
| 3 Years: | -3% |
| 1 Year: | -26% |
| Return on Equity | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | -3% |
| 3 Years: | 2% |
| Last Year: | -1% |
Last Updated: September 5, 2025, 1:05 pm
Balance Sheet
Last Updated: December 4, 2025, 1:53 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 11 | 11 | 11 | 11 | 12 | 12 | 12 | 12 | 13 | 13 | 14 | 14 | 14 |
| Reserves | 191 | 187 | 172 | 145 | 211 | 236 | 285 | 242 | 256 | 284 | 369 | 368 | 345 |
| Borrowings | 229 | 208 | 192 | 236 | 143 | 150 | 165 | 140 | 102 | 96 | 49 | 99 | 127 |
| Other Liabilities | 67 | 74 | 76 | 49 | 52 | 81 | 56 | 74 | 58 | 70 | 66 | 66 | 93 |
| Total Liabilities | 497 | 480 | 451 | 441 | 418 | 479 | 518 | 468 | 429 | 463 | 498 | 547 | 580 |
| Fixed Assets | 211 | 199 | 198 | 233 | 231 | 233 | 260 | 291 | 255 | 250 | 224 | 275 | 351 |
| CWIP | 1 | 0 | 5 | 4 | 1 | 2 | 50 | 9 | 4 | 11 | 50 | 49 | 9 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 2 | 3 |
| Other Assets | 285 | 281 | 249 | 205 | 186 | 244 | 208 | 168 | 169 | 201 | 224 | 221 | 217 |
| Total Assets | 497 | 480 | 451 | 441 | 418 | 479 | 518 | 468 | 429 | 463 | 498 | 547 | 580 |
Below is a detailed analysis of the balance sheet data for Repro India Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 14.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 14.00 Cr..
- For Reserves, as of Sep 2025, the value is 345.00 Cr.. The value appears to be declining and may need further review. It has decreased from 368.00 Cr. (Mar 2025) to 345.00 Cr., marking a decrease of 23.00 Cr..
- For Borrowings, as of Sep 2025, the value is 127.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 99.00 Cr. (Mar 2025) to 127.00 Cr., marking an increase of 28.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 93.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 66.00 Cr. (Mar 2025) to 93.00 Cr., marking an increase of 27.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 580.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 547.00 Cr. (Mar 2025) to 580.00 Cr., marking an increase of 33.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 351.00 Cr.. The value appears strong and on an upward trend. It has increased from 275.00 Cr. (Mar 2025) to 351.00 Cr., marking an increase of 76.00 Cr..
- For CWIP, as of Sep 2025, the value is 9.00 Cr.. The value appears to be declining and may need further review. It has decreased from 49.00 Cr. (Mar 2025) to 9.00 Cr., marking a decrease of 40.00 Cr..
- For Investments, as of Sep 2025, the value is 3.00 Cr.. The value appears strong and on an upward trend. It has increased from 2.00 Cr. (Mar 2025) to 3.00 Cr., marking an increase of 1.00 Cr..
- For Other Assets, as of Sep 2025, the value is 217.00 Cr.. The value appears to be declining and may need further review. It has decreased from 221.00 Cr. (Mar 2025) to 217.00 Cr., marking a decrease of 4.00 Cr..
- For Total Assets, as of Sep 2025, the value is 580.00 Cr.. The value appears strong and on an upward trend. It has increased from 547.00 Cr. (Mar 2025) to 580.00 Cr., marking an increase of 33.00 Cr..
Notably, the Reserves (345.00 Cr.) exceed the Borrowings (127.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -161.00 | -161.00 | -166.00 | -211.00 | -129.00 | -105.00 | -119.00 | -145.00 | -89.00 | -52.00 | 3.00 | -67.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 125 | 157 | 142 | 102 | 109 | 105 | 105 | 211 | 81 | 59 | 61 | 48 |
| Inventory Days | 60 | 42 | 60 | 70 | 98 | 102 | 78 | 147 | 95 | 92 | 65 | 73 |
| Days Payable | 46 | 60 | 70 | 66 | 84 | 98 | 68 | 173 | 97 | 84 | 67 | 70 |
| Cash Conversion Cycle | 139 | 139 | 132 | 106 | 123 | 109 | 116 | 184 | 79 | 67 | 58 | 50 |
| Working Capital Days | -17 | 2 | 4 | -104 | -24 | -6 | -5 | -13 | 16 | 42 | 56 | 29 |
| ROCE % | 13% | 9% | 2% | 3% | 7% | 8% | 6% | -7% | -3% | 5% | 6% | 2% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | -1.44 | 8.77 | 6.87 | -18.74 | -35.88 |
| Diluted EPS (Rs.) | -1.44 | 8.66 | 6.84 | -18.74 | -35.88 |
| Cash EPS (Rs.) | 20.44 | 29.21 | 26.27 | 2.81 | -12.85 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 266.90 | 270.89 | 232.99 | 211.28 | 210.06 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 266.90 | 270.89 | 232.99 | 211.28 | 210.06 |
| Revenue From Operations / Share (Rs.) | 325.38 | 335.29 | 331.46 | 226.15 | 114.19 |
| PBDIT / Share (Rs.) | 26.72 | 37.67 | 34.67 | 10.55 | -4.39 |
| PBIT / Share (Rs.) | 4.85 | 16.92 | 15.26 | -10.50 | -27.43 |
| PBT / Share (Rs.) | -1.06 | 10.12 | 6.79 | -18.93 | -38.49 |
| Net Profit / Share (Rs.) | -1.44 | 8.46 | 6.86 | -18.25 | -35.88 |
| NP After MI And SOA / Share (Rs.) | -1.44 | 8.46 | 6.86 | -18.25 | -35.88 |
| PBDIT Margin (%) | 8.21 | 11.23 | 10.46 | 4.66 | -3.84 |
| PBIT Margin (%) | 1.48 | 5.04 | 4.60 | -4.64 | -24.01 |
| PBT Margin (%) | -0.32 | 3.01 | 2.05 | -8.37 | -33.71 |
| Net Profit Margin (%) | -0.44 | 2.52 | 2.06 | -8.06 | -31.42 |
| NP After MI And SOA Margin (%) | -0.44 | 2.52 | 2.06 | -8.06 | -31.42 |
| Return on Networth / Equity (%) | -0.53 | 3.12 | 2.94 | -8.63 | -17.08 |
| Return on Capital Employeed (%) | 1.62 | 5.94 | 5.39 | -4.16 | -9.69 |
| Return On Assets (%) | -0.37 | 2.41 | 1.88 | -5.40 | -9.26 |
| Long Term Debt / Equity (X) | 0.05 | 0.00 | 0.12 | 0.07 | 0.22 |
| Total Debt / Equity (X) | 0.18 | 0.07 | 0.22 | 0.24 | 0.34 |
| Asset Turnover Ratio (%) | 0.88 | 0.99 | 0.68 | 0.44 | 0.21 |
| Current Ratio (X) | 1.41 | 1.87 | 1.53 | 1.18 | 0.98 |
| Quick Ratio (X) | 0.97 | 1.38 | 0.97 | 0.81 | 0.76 |
| Inventory Turnover Ratio (X) | 9.42 | 4.96 | 3.81 | 3.22 | 1.57 |
| Interest Coverage Ratio (X) | 4.52 | 5.54 | 4.09 | 1.25 | -0.39 |
| Interest Coverage Ratio (Post Tax) (X) | 0.75 | 2.24 | 1.81 | -1.17 | -2.24 |
| Enterprise Value (Cr.) | 631.33 | 1210.32 | 514.76 | 562.34 | 501.35 |
| EV / Net Operating Revenue (X) | 1.35 | 2.52 | 1.22 | 1.96 | 3.63 |
| EV / EBITDA (X) | 16.50 | 22.47 | 11.66 | 41.93 | -94.47 |
| MarketCap / Net Operating Revenue (X) | 1.22 | 2.48 | 1.08 | 1.75 | 3.04 |
| Price / BV (X) | 1.49 | 3.07 | 1.53 | 1.87 | 1.65 |
| Price / Net Operating Revenue (X) | 1.22 | 2.48 | 1.08 | 1.75 | 3.04 |
| EarningsYield | 0.00 | 0.01 | 0.01 | -0.04 | -0.10 |
After reviewing the key financial ratios for Repro India Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is -1.44. This value is below the healthy minimum of 5. It has decreased from 8.77 (Mar 24) to -1.44, marking a decrease of 10.21.
- For Diluted EPS (Rs.), as of Mar 25, the value is -1.44. This value is below the healthy minimum of 5. It has decreased from 8.66 (Mar 24) to -1.44, marking a decrease of 10.10.
- For Cash EPS (Rs.), as of Mar 25, the value is 20.44. This value is within the healthy range. It has decreased from 29.21 (Mar 24) to 20.44, marking a decrease of 8.77.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 266.90. It has decreased from 270.89 (Mar 24) to 266.90, marking a decrease of 3.99.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 266.90. It has decreased from 270.89 (Mar 24) to 266.90, marking a decrease of 3.99.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 325.38. It has decreased from 335.29 (Mar 24) to 325.38, marking a decrease of 9.91.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 26.72. This value is within the healthy range. It has decreased from 37.67 (Mar 24) to 26.72, marking a decrease of 10.95.
- For PBIT / Share (Rs.), as of Mar 25, the value is 4.85. This value is within the healthy range. It has decreased from 16.92 (Mar 24) to 4.85, marking a decrease of 12.07.
- For PBT / Share (Rs.), as of Mar 25, the value is -1.06. This value is below the healthy minimum of 0. It has decreased from 10.12 (Mar 24) to -1.06, marking a decrease of 11.18.
- For Net Profit / Share (Rs.), as of Mar 25, the value is -1.44. This value is below the healthy minimum of 2. It has decreased from 8.46 (Mar 24) to -1.44, marking a decrease of 9.90.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is -1.44. This value is below the healthy minimum of 2. It has decreased from 8.46 (Mar 24) to -1.44, marking a decrease of 9.90.
- For PBDIT Margin (%), as of Mar 25, the value is 8.21. This value is below the healthy minimum of 10. It has decreased from 11.23 (Mar 24) to 8.21, marking a decrease of 3.02.
- For PBIT Margin (%), as of Mar 25, the value is 1.48. This value is below the healthy minimum of 10. It has decreased from 5.04 (Mar 24) to 1.48, marking a decrease of 3.56.
- For PBT Margin (%), as of Mar 25, the value is -0.32. This value is below the healthy minimum of 10. It has decreased from 3.01 (Mar 24) to -0.32, marking a decrease of 3.33.
- For Net Profit Margin (%), as of Mar 25, the value is -0.44. This value is below the healthy minimum of 5. It has decreased from 2.52 (Mar 24) to -0.44, marking a decrease of 2.96.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is -0.44. This value is below the healthy minimum of 8. It has decreased from 2.52 (Mar 24) to -0.44, marking a decrease of 2.96.
- For Return on Networth / Equity (%), as of Mar 25, the value is -0.53. This value is below the healthy minimum of 15. It has decreased from 3.12 (Mar 24) to -0.53, marking a decrease of 3.65.
- For Return on Capital Employeed (%), as of Mar 25, the value is 1.62. This value is below the healthy minimum of 10. It has decreased from 5.94 (Mar 24) to 1.62, marking a decrease of 4.32.
- For Return On Assets (%), as of Mar 25, the value is -0.37. This value is below the healthy minimum of 5. It has decreased from 2.41 (Mar 24) to -0.37, marking a decrease of 2.78.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.05. This value is below the healthy minimum of 0.2. It has increased from 0.00 (Mar 24) to 0.05, marking an increase of 0.05.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.18. This value is within the healthy range. It has increased from 0.07 (Mar 24) to 0.18, marking an increase of 0.11.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.88. It has decreased from 0.99 (Mar 24) to 0.88, marking a decrease of 0.11.
- For Current Ratio (X), as of Mar 25, the value is 1.41. This value is below the healthy minimum of 1.5. It has decreased from 1.87 (Mar 24) to 1.41, marking a decrease of 0.46.
- For Quick Ratio (X), as of Mar 25, the value is 0.97. This value is below the healthy minimum of 1. It has decreased from 1.38 (Mar 24) to 0.97, marking a decrease of 0.41.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 9.42. This value exceeds the healthy maximum of 8. It has increased from 4.96 (Mar 24) to 9.42, marking an increase of 4.46.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 4.52. This value is within the healthy range. It has decreased from 5.54 (Mar 24) to 4.52, marking a decrease of 1.02.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 0.75. This value is below the healthy minimum of 3. It has decreased from 2.24 (Mar 24) to 0.75, marking a decrease of 1.49.
- For Enterprise Value (Cr.), as of Mar 25, the value is 631.33. It has decreased from 1,210.32 (Mar 24) to 631.33, marking a decrease of 578.99.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.35. This value is within the healthy range. It has decreased from 2.52 (Mar 24) to 1.35, marking a decrease of 1.17.
- For EV / EBITDA (X), as of Mar 25, the value is 16.50. This value exceeds the healthy maximum of 15. It has decreased from 22.47 (Mar 24) to 16.50, marking a decrease of 5.97.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.22. This value is within the healthy range. It has decreased from 2.48 (Mar 24) to 1.22, marking a decrease of 1.26.
- For Price / BV (X), as of Mar 25, the value is 1.49. This value is within the healthy range. It has decreased from 3.07 (Mar 24) to 1.49, marking a decrease of 1.58.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.22. This value is within the healthy range. It has decreased from 2.48 (Mar 24) to 1.22, marking a decrease of 1.26.
- For EarningsYield, as of Mar 25, the value is 0.00. This value is below the healthy minimum of 5. It has decreased from 0.01 (Mar 24) to 0.00, marking a decrease of 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Repro India Ltd:
- Net Profit Margin: -0.44%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 1.62% (Industry Average ROCE: 9.42%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: -0.53% (Industry Average ROE: 9.72%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 0.75
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.97
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 0 (Industry average Stock P/E: 84.29)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.18
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: -0.44%
About the Company
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Printing/Publishing/Stationery | 11th Floor, Sun Paradise Business Plaza, B wing, Senapati Bapat Marg, Mumbai Maharashtra 400013 | investor@reproindialtd.com http://www.reproindialtd.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Vinod Vohra | Chairman |
| Mr. Sanjeev Vohra | Managing Director |
| Mr. Mukesh Dhruve | Executive Director |
| Mr. Rajeev Vohra | Executive Director |
| Mr. Ullal R Bhat | Ind. Non-Executive Director |
| Mr. Dushyant Mehta | Ind. Non-Executive Director |
| Mrs. Mahalakshmi Ramadorai | Ind. Non-Executive Director |
| Ms. Bhumika Batra | Ind. Non-Executive Director |
Repro India Ltd. Share Price Update | |
|---|---|
| Share Price | Value |
| Today | ₹770.65 |
| Previous Day | ₹770.70 |
FAQ
What is the intrinsic value of Repro India Ltd?
Repro India Ltd's intrinsic value (as of 08 December 2025) is 15.67 which is 96.47% lower the current market price of 444.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 637 Cr. market cap, FY2025-2026 high/low of 687/380, reserves of ₹345 Cr, and liabilities of 580 Cr.
What is the Market Cap of Repro India Ltd?
The Market Cap of Repro India Ltd is 637 Cr..
What is the current Stock Price of Repro India Ltd as on 08 December 2025?
The current stock price of Repro India Ltd as on 08 December 2025 is 444.
What is the High / Low of Repro India Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Repro India Ltd stocks is 687/380.
What is the Stock P/E of Repro India Ltd?
The Stock P/E of Repro India Ltd is .
What is the Book Value of Repro India Ltd?
The Book Value of Repro India Ltd is 251.
What is the Dividend Yield of Repro India Ltd?
The Dividend Yield of Repro India Ltd is 0.00 %.
What is the ROCE of Repro India Ltd?
The ROCE of Repro India Ltd is 1.56 %.
What is the ROE of Repro India Ltd?
The ROE of Repro India Ltd is 0.51 %.
What is the Face Value of Repro India Ltd?
The Face Value of Repro India Ltd is 10.0.